Can rapamycin reverse or prevent grey hair?
Rapamycin shows interesting effects on pigmentation in the lab and in a rare hereditary disease, but there is no evidence whatsoever that it reverses or prevents grey hair in healthy people.
Grey hair follicles that still contained living pigment cells showed increased pigment production in laboratory experiments after treatment with rapamycin. Those follicles also had higher activity of a growth-stimulating protein switch (mTORC1) than pigmented follicles. This suggests that overactive mTORC1 contributes to greying, and that inhibiting it can slow that process. This has been observed exclusively in cultured human hair follicles outside the body, not in a human trial.
More compelling evidence comes from studies in a rare hereditary disease called tuberous sclerosis. In people and mice with this condition, a specific genetic defect causes chronic overactivation of that same mTORC1 switch, which suppresses pigment production at its source. In mice, rapamycin completely reversed the depigmentation. In patients with tuberous sclerosis, both topical and systemic rapamycin partially restored pigmentation. However, this is a very different situation from ordinary ageing: in tuberous sclerosis one specific gene is switched off, whereas in normal greying dozens of factors play a role simultaneously.
For healthy people without tuberous sclerosis, there is simply no research. None of the available studies tested rapamycin in ordinary, age-related greying in humans. Whether the laboratory results are also clinically relevant outside that specific genetic context is currently unknown. Rapamycin also suppresses the immune system and has serious side effects; it is used clinically in organ transplantation and in TSC, not as a cosmetic agent.
All claims are based on four studies (PMID 37212043, 29146131, 27918305, 29080681). These consist of laboratory, cell and animal research, plus limited data from TSC patients. There is no randomised trial or larger human study in ordinary greying.
Does rapamycin improve skin aging?
Topical rapamycin showed promising signs for skin ageing in a small study, but the evidence is still too thin to justify self-application.
Does red light therapy really help against skin ageing?
Red light therapy measurably reduces wrinkles and skin roughness, with the strongest support coming from professional treatments involving multiple sessions. For home devices, the evidence is still too thin to promise the same effect.
Does retinol help against wrinkles?
Retinol demonstrably works against wrinkles and improves skin texture, although tretinoin is more potent for those who can or wish to obtain a prescription; people who experience irritation may consider bakuchiol as an equivalent alternative based on one small study.
Do peptides in skincare actually do anything?
Peptides in creams have a plausible mechanism on paper, but clinical evidence for topical use is thin. If you want to do something about skin ageing, oral collagen currently has the stronger foundation, though that too should be interpreted with some caution.
Does rapamycin help people live longer in good health?
Rapamycin works in mice, but whether it also leads to a longer and healthier life in humans has not yet been demonstrated. Side effects are real, long-term data in healthy people are absent, and use outside a clinical context cannot currently be justified.
What do we know about rapamycin as an anti-ageing agent in humans?
Rapamycin shows early positive signals in humans for immune function and skin, but long-term safety is unknown and side effects such as infections and unfavourable blood lipids are a real risk. Use outside a clinical trial is premature.